Mylan Rolls Out Semglee Insulin In Australia

 
• By Aidan Fry

Immediately upon reimbursement listing, Mylan has launched in Australia the insulin glargine biosimilar that it co-developed with India’s Biocon. 

Australia
Australian diabetics now how another treatment option with the launch of Mylan's Semglee insulin glargine biosimilar • Source: Shutterstock

More from Biosimilars

More from Products